In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1844 News Items found
A researcher working in an MSK lab
MSK Research Highlights, March 3, 2025

New MSK research identifies new cancer-specific targets for T cell receptor immunotherapy approaches; sheds light on a critical process in sexual reproduction; describes how regulatory T cells help prevent intestinal inflammation; and uncovers how the spleen helps natural killer immune cells adapt to new threats.
Rosario Costas-Muñiz is a psycho-oncologist focused on the needs of the Latino community.
Helping Latinos Prevent Colon Cancer: Good News about Screening

Learn from an MSK specialist in cancer care for the Latino community about screening for colorectal cancer, to help prevent the disease.
woman getting vaccine from doctor
HPV Vaccine Age Limit: You Might Not Be Too Old — What You Should Know

Learn from MSK experts what people over 26 should know about getting the HPV vaccine to protect themselves from several forms of cancer.
Colorectal Surgeon Dr. Julio Garcia-Aguilar seen in exam room with Nurse Kieran Kelleher
Why Watch and Wait Instead of Rectal Cancer Surgery May Be Right for You

Learn how MSK uses the watch-and-wait approach to rectal cancer, which can preserve people's quality of life by successfully treating rectal cancer without removing the rectum.
In the Lab
MSK Biochemist and bioengineer Dr. Kayvan Keshari
How Reprogrammed Immune Cells Can Use Fructose To Fight Cancer

Learn how engineering immune cells to metabolize fructose could supercharge them to fight cancer.
(Clockwise from upper left) Dr. Tal Cohen, Dr. Doris Ponce, Dr. Sandeep Raj, Dr. Jonathan Peled, Dr. Yeon Joo Lee, Dr. Sergio Giralt, and Winston Chang.
MSK Experts Present Advances in Bone Marrow Transplant and Cellular Therapy Research at Prestigious Conference

Physicians and scientists from MSK presented advances in transplantation and cellular therapies at the Tandem Meetings, a joint event hosted by the American Society for Transplantation and Cellular Therapy and the Center for International Blood and Marrow Transplant Research.
Atomic force microscopy image of hepatitis B wrapped around human histones
Digging Into a Decades-Old Hepatitis B Mystery Suggests a New Potential Treatment

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by MSK, Weill Cornell Medicine, and The Rockefeller University identified a vulnerability that opens the door to new treatments.
Dr. William Tap
FDA Approves Vimseltinib for Tenosynovial Giant Cell Tumor (TGCT)

The U.S. Food and Drug Administration has approved vimseltinib for adult patients with a rare condition called tenosynovial giant cell tumor, based on a trial led by an MSK researcher.
MSK physician-scientist Vinod Balachandran.
In Early-Phase Pancreatic Cancer Clinical Trial, Investigational mRNA Vaccine Induces Sustained Immune Activity in Small Patient Group

Learn how MSK researchers are deploying mRNA vaccines against pancreatic cancer.
A researcher working in an MSK lab
MSK Research Highlights, February 13, 2025

New MSK research supported the approval of a new treatment for ER-positive, HER2-negative advanced breast cancer; suggests a new strategy for overcoming resistance to Akt inhibitors in patients with PTEN-mutated prostate cancers; provides new understanding of B cell lymphomas that could lead to new treatments; examines using ChatGPT to help capture patient-reported outcomes; and developed the first customizable, scalable model for palliative care training for emergency departments.